Literature DB >> 3600238

Physiological response to circuit weight training in borderline hypertensive subjects.

K A Harris, R G Holly.   

Abstract

Male subjects (10 experimental, 16 control) with borderline hypertension (140/90 to 160/95 mm Hg) participated in a circuit weight training program for 9 wk to assess its efficacy and safety. Resting blood pressure and heart rate were measured under standardized conditions prior to and following each session and at several locations in the circuit. Subjects were assessed pre- and post-training. Upper and lower body strength increased 12.5 and 53% when assessed by one-repetition maximum lifts for bench press (57 to 64 kg) and leg press (134 to 205 kg), respectively. Total weight lifted per circuit increased 57% (4,374 to 6,866 kg). Lean body mass increased 2.2% (64.0 to 65.4 kg), skinfold thicknesses decreased, and other measures of body composition remained unchanged. Cardiovascular endurance as assessed by arm ergometry maximal oxygen uptake increased 21.1% (1.9 to 2.3 1 X min-1), and by 7.8% as assessed by treadmill maximal oxygen uptake (40.9 to 44.1 ml X kg-1 X min-1). Resting heart rate and systolic blood pressure did not change. Diastolic blood pressure fell from 95.8 to 91.3 mm Hg. All changes were significant to at least P less than 0.05. Thus, circuit weight training can elicit marked improvements in muscular strength and modest improvements in body composition and cardiorespiratory endurance. Circuit weight training does not exacerbate resting or exercise blood pressure and may have beneficial effects.

Entities:  

Mesh:

Year:  1987        PMID: 3600238

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  22 in total

1.  Atenolol blunts blood pressure increase during dynamic resistance exercise in hypertensives.

Authors:  Ricardo S Gomides; Luiz A R Costa; Dinoélia R Souza; Andréia C C Queiroz; João R C Fernandes; Kátia C Ortega; Décio Mion Junior; Taís Tinucci; Cláudia L M Forjaz
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

2.  Effect of breathing techniques on blood pressure response to resistance exercise.

Authors:  S T Linsenbardt; T R Thomas; R W Madsen
Journal:  Br J Sports Med       Date:  1992-06       Impact factor: 13.800

Review 3.  Musculoskeletal fitness, health outcomes and quality of life.

Authors:  R T Kell; G Bell; A Quinney
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

Review 4.  Resistive exercise training in cardiac patients. Recommendations.

Authors:  D Verrill; E Shoup; G McElveen; K Witt; D Bergey
Journal:  Sports Med       Date:  1992-03       Impact factor: 11.136

Review 5.  Coronary heart disease risk factors in the physically active. Impact of exercise.

Authors:  L B Andersen; M Hippe
Journal:  Sports Med       Date:  1996-10       Impact factor: 11.136

Review 6.  Resistive exercise training in cardiac rehabilitation. An update.

Authors:  D E Verrill; P M Ribisl
Journal:  Sports Med       Date:  1996-05       Impact factor: 11.136

7.  The benefit of strength training on arterial blood pressure in patients with type 2 diabetes mellitus measured with ambulatory 24-hour blood pressure systems.

Authors:  Barbara Strasser; Paul Haber; Christoph Strehblow; Edmund Cauza
Journal:  Wien Med Wochenschr       Date:  2008

8.  Intra-arterial blood pressure response in hypertensive subjects during low- and high-intensity resistance exercise.

Authors:  Sandra de Souza Nery; Ricardo Saraceni Gomides; Giovanio Vieira da Silva; Claudia Lucia de Moraes Forjaz; Décio Mion; Tais Tinucci
Journal:  Clinics (Sao Paulo)       Date:  2010-03       Impact factor: 2.365

Review 9.  Weightlifting training in cardiac patients. Considerations.

Authors:  R S McKelvie; N McCartney
Journal:  Sports Med       Date:  1990-12       Impact factor: 11.136

Review 10.  Exercise and mild essential hypertension. Recommendations for adults.

Authors:  N F Gordon; C B Scott; W J Wilkinson; J J Duncan; S N Blair
Journal:  Sports Med       Date:  1990-12       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.